Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

2019-nCoV Clinical Trial

Official title:
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Status Active, not recruiting

Clinical Trial Summary

Compare the efficacy and safety of Bromhexine Hydrochloride Tablets combined with standard treatment/ standard treatment in patients with suspected and mild, or common novel coronavirus pneumonia (COVID-19).

Random, open, group sequential design.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04273763
Study type	Interventional
Source	Second Affiliated Hospital of Wenzhou Medical University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 16, 2020
Completion date	June 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT04334967` - Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care	Phase 4
Not yet recruiting	`NCT04264858` - Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients	N/A
Withdrawn	`NCT04272710` - Prognositc Factors in COVID-19 Patients Complicated With Hypertension
Completed	`NCT04260594` - Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus	Phase 4
Not yet recruiting	`NCT04270383` - Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
Terminated	`NCT04261907` - Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection	N/A
Not yet recruiting	`NCT04261426` - The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia	Phase 2/Phase 3
Recruiting	`NCT04254874` - A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia	Phase 4
Recruiting	`NCT04255017` - A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia	Phase 4
Not yet recruiting	`NCT04356508` - COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1	Phase 2
Terminated	`NCT04321928` - Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary	N/A